These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 1978251
1. Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Gough AC, Miles JS, Spurr NK, Moss JE, Gaedigk A, Eichelbaum M, Wolf CR. Nature; 1990 Oct 25; 347(6295):773-6. PubMed ID: 1978251 [Abstract] [Full Text] [Related]
2. Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals. Wolf CR. IARC Sci Publ; 1991 Oct 25; (115):281-7. PubMed ID: 1820342 [Abstract] [Full Text] [Related]
3. Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene. Broly F, Meyer UA. Pharmacogenetics; 1993 Jun 25; 3(3):123-30. PubMed ID: 8101460 [Abstract] [Full Text] [Related]
5. Polymorphism of human CYP2D genes involved in drug metabolism: possible relationship to individual cancer risk. Nebert DW. Cancer Cells; 1991 Mar 25; 3(3):93-6. PubMed ID: 2054261 [No Abstract] [Full Text] [Related]
6. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. Dahl ML, Johansson I, Bertilsson L, Ingelman-Sundberg M, Sjöqvist F. J Pharmacol Exp Ther; 1995 Jul 25; 274(1):516-20. PubMed ID: 7616439 [Abstract] [Full Text] [Related]
7. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M. J Pharmacol Exp Ther; 1996 Jul 25; 278(1):441-6. PubMed ID: 8764380 [Abstract] [Full Text] [Related]
11. Debrisoquine polymorphism: novel CYP2D6 gene Bam HI restriction fragment length polymorphism in the Ngawbé Guaymí Indian of Panama. Petersen DD, Kong AN, Jorge LF, Nebert DW, Arias TD. Pharmacogenetics; 1991 Dec 25; 1(3):136-42. PubMed ID: 1688244 [Abstract] [Full Text] [Related]
12. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Johansson I, Lundqvist E, Bertilsson L, Dahl ML, Sjöqvist F, Ingelman-Sundberg M. Proc Natl Acad Sci U S A; 1993 Dec 15; 90(24):11825-9. PubMed ID: 7903454 [Abstract] [Full Text] [Related]
15. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk. Roots I, Drakoulis N, Ploch M, Heinemeyer G, Loddenkemper R, Minks T, Nitz M, Otte F, Koch M. Klin Wochenschr; 1988 Dec 15; 66 Suppl 11():87-97. PubMed ID: 2846954 [Abstract] [Full Text] [Related]
16. [Study of transcription of the human cytochrome P450IID6 gene by polymerase chain reaction]. Krynetskiĭ EIu, Kovaleva IE. Mol Biol (Mosk); 1992 Dec 15; 26(4):943-8. PubMed ID: 1435785 [Abstract] [Full Text] [Related]